FGF/FGFR system inhibition as a therapeutic strategy for high-risk and chemoresistant medulloblastom in Rome

FGF/FGFR system inhibition as a therapeutic strategy for high-risk and chemoresistant medulloblastom in Rome

Rome Full-Time In sede
I

Organisation/Company Università degli studi di Brescia Research Field Medical sciences » Medicine Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 1 Dec 2026 - 14:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description

Medulloblastoma (MB) is the most common malignant pediatric brain tumor. MB-SHH tumors with TP53 mutation and Group 3 MB, often characterized by high aggressiveness, dissemination and treatment resistance, require novel targeted strategies. The project will investigate the role of FGF/FGFR signaling and the therapeutic potential of its blockade using clinically available FGFR inhibitors and next-generation FGF-trap molecules. Murine and human cell models, primary cells, patient-derived xenograft organoids and orthotopic in vivo models will be used. Effects on tumor growth, cell signaling and the tumor microenvironment will be characterized, together with the efficacy of combination treatments with conventional and innovative chemotherapies. Particular attention will be given to chemoresistant models to determine whether FGF/FGFR targeting can overcome resistance and prevent relapse. The evaluation criteria are established in the call; a master's degree obtained no more than six years ago is required; knowledge of Italian and English is required. The professional expertise considered preferable for the purposes of the intended collaboration will relate to experience in cellular biology, molecular biology, the study of the tumor microenvironment, and in vivo models in experimental oncology. OTHER Eligibility of fellows: country/ies of residence: OTHER Eligibility of fellows: nationality/ies: OTHER Selection process

Public notice for the direct approval of a research position pursuant to Article 22-ter, paragraph 4, of Law No. 240/2010, a.d. MEDS-02/A “Experimental Medicine and Pathophysiology

FGF/FGFR system inhibition as a therapeutic strategy for high-risk and chemoresistant medulloblastom in Rome datore di lavoro: Italian Ministry of Education, University and Research

L'Università degli Studi di Roma Tor Vergata offre un ambiente di lavoro stimolante e collaborativo, ideale per i ricercatori che desiderano contribuire a metodologie innovative nel campo della geotecnica. Con opportunità di crescita professionale e accesso a risorse all'avanguardia, i dipendenti possono sviluppare le proprie competenze in un contesto accademico di eccellenza, immerso nella vibrante cultura di Roma.

I

Dettagli di contatto:

Team di recruiting di Italian Ministry of Education, University and Research